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Abstract 
The development of drug-resistant bacteria and the necessity for unique antimicrobial agents, directed to the search of new 
habitats to screen the production of anti-infective substances. Culture-dependent studies of heterotrophic bacteria from the 
intertidal macroalgae thriving along the Southern coast of India resulted in the isolation of 148 strains, which were assayed 
for antibacterial activities against wide spectrum of pathogens including drug-resistant pathogens, methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE). Two of the most active strains 
with a zone of inhibition ≥ 30 mm on spot over lawn assay, belonging to the phyla Firmicutes and Gamma-proteobacteria, 
isolated from a  Rhodophycean marine macroalga, Hypnea valentiae, were selected for bioprospecting studies. They were 
further characterized as Shewanella algae MTCC 12715 and Bacillus amyloliquefaciens MTCC 12716, based on integrated 
phenotypic and genotypic analysis. The bacterial extracts exhibited significant antibacterial activities against MRSA and 
VRE with minimum inhibitory concentrations of 6.25–12.5 µg/mL. Time kill kinetic profiles of these bacteria revealed rapid 
bactericidal activity against both MRSA and E. coli, showing a ≥ 3log10 decline in viable cell count compared to the initial. 
In BacLight™ live/dead staining technique, the propidium iodide uptake results appropriately attributed that the components 
in the B. amyloliquefaciens extract might compromise the integrity of the cytoplasmic membrane of the pathogenic bacteria. 
Type-1 pks gene (MH157093) of S. algae and hybrid nrps/pks gene (MH157092) of B. amyloliquefaciens could be amplified. 
Antibacterial activity study combined with the results of amplified genes coding for polyketide synthase and nonribosomal 
peptide synthetase showed that these marine symbiotic bacteria had a promising broad-spectrum activity, and therefore, 
could be used against the emerging dilemma of antibiotic-resistant bacterial infections.
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Introduction
Marine macroalgae and their symbiotic bacterial communi-
ties are potential sources in the field of biotechnology as a 
result of their production of a wide diversity of metabolites 
with wide range of bioactivities (Zubia et al. 2009; Le Lann 
et al. 2016). Microbes with inhibitory traits were found to 
reside symbiotically on the surface of marine macroalgae, 
providing it with a microorganism-mediated defence com-
munity (Kumar et al. 2011; Penesyan et al. 2009; Albakosh 
et al. 2016; Xiong et al. 2018). The interest in bacterial pop-
ulaces living in relationship with marine macroalgae has 
expanded amid the recent decades to control food-borne 
pathogens as a result of the rise of antibiotic-resistant bac-
teria, and the need for new antimicrobial compounds. The 
retrieval of marine macroalgae associated bacterial strains 
with antimicrobial activity suggests that marine macroal-
gae represent an ecological niche, which harbours a specific 
microbial diversity with potential biotechnological and phar-
maceutical interests (Kanagasabhapathy et al. 2008). The 
search for new antibiotics and pharmacophores possessing 
potential anti-infective properties is necessary because of 
the evolving trend of resistance in infectious microbes to 
the existing compounds (Strobel and Daisy 2003). Marine 
microorganisms have developed exceptional metabolites and 
physiological competencies, which not only make sure sur-
vival in extreme habitats, but also offer the potential for the 
production of metabolites not apparent in their terrestrial 
counterparts (Garson 2001). Moreover, numerous researches 
have proved that the actual producers of majority of the 
marine bioactive compounds are not the eukaryotes them-
selves, but the symbiotic microorganisms associated with 
them (Kubanek et al. 2003; Li 2009). From a biotechnologi-
cal point of view, the production of signalling molecules, 
toxins and other secondary metabolites as effective antago-
nism and defence propositions by symbiotic microorgan-
isms compose an incomparable repository for the discovery 
of novel bioactive compounds, pharmaceutical agents and 
drug molecules, with applications in medical, environmental 
and industrial areas. Even though, the great biotechnological 
prospective of marine symbiotic microorganisms remains 
generally untapped (Egan et al. 2008).
Marine macroalgae constitute one of the vast and 
diverse ecosystems contributing a vital role in marine 
environment in global primary production and provides 
protected and nutrient rich environment for range of organ-
isms. Hence, compared to other eukaryotic hosts, macroal-
gae are rich in diversity of associated microbes (Armstrong 
et al. 2001). In particular, the surface-associated bacterial 
species have been stated as essential for the growth and 
development of macroalgae, and the bacteria with antag-
onistic potentials are supposed to shield the macroalgae 
from pathogens as well as other surface colonizing com-
petitors (Avendaño-Herrera 2005). Some bacterial strains 
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display bactericidal property and host specificity against 
particular pathogens involving complex biochemical con-
nections between macroalgae and microbes (Strobel and 
Daisy 2003).
Various researches were focused on the antifouling and 
antibiotic activities of macroalgae-associated bacterial spe-
cies (Zheng et al. 2005; Kanagasabhapathy et al. 2008; 
Penesyan et al. 2009; Wiese et al. 2009; Chakraborty et al. 
2018). In 1997, Imamura et al. reported the production of a 
phenazine compound with antimicrobial activity, by a strain 
of Pelagiobacter variabilis isolated from the brown marine 
macroalgae Pocockiella variegata. Antibacterial activity of 
Bacillus licheniformis associated with intertidal macroal-
gae Fucus serratus against MRSA and VRE were described 
earlier by Jamal et al. (2006). Culture-based studies indi-
cated that symbiotic bacteria display a great potential to 
produce bioactive compounds, which were found to inhibit 
the growth of environmental pathogens, laboratory strains 
and also human pathogens (Kizhakkekalam and Chakraborty 
2019). Highly competitive environment as well as space and 
nutrient limitation, forces surface inhabiting microorganisms 
to evolve specific adaptive methods as well as antagonistic 
tactics to prevent colonization or growth of possible com-
petitors (Egan et al. 2008).
Polyketides and nonribosomal peptides were found to 
account for a significant share of identified natural products, 
and have been the major source of potential pharmacophore 
candidates (Walsh 2004). Intensive research on nrps (non-
ribosomal peptide synthetase) and pks-I (type I polyketide 
synthase) provide a great avenue to the identification and 
application of novel secondary metabolites in biotechnol-
ogy and biomedicine (Amoutzias et al. 2008). An increasing 
number of gene clusters encoding nrps, type I pks and their 
hybrids were recognized for biosynthesis of complicated 
natural products (Wang et al. 2014). Also, Wang et al. (2014) 
reported the widespread dispersal of nrps and modular pks 
biosynthetic genes in higher numbers among Proteobacte-
ria, Actinobacteria, and Firmicutes.
The major difficulties, which have hindered the develop-
ment of drugs from marine natural products are the supply 
issues (Martins et al. 2014). Structure complexity and rich 
in centres of asymmetry are limiting the large-scale prepara-
tion of antibiotics by chemical synthesis, of majority of the 
promising marine compounds (Davidson 1995). Moreover, 
the yield from harvesting and isolating from microorganisms 
might be quite low because the microorganisms are rare or 
the active compound is a minor constituent (Kasanah and 
Hamann 2004). In the meantime it is hard to collect infinite 
amounts of marine animal or plant material, whereas the iso-
lation and culturing of associated microorganisms are impor-
tant for an adequate and constant supply of bioactive natural 
products. Host associated marine microbes, which could be 
cultivated would aid in future development of marine natural 
product leads if the compound could be produced by a sym-
biotic microorganism (Kobayashi and Ishibashi 1993).
With the expanding requirement for novel medication 
against antibiotic-resistant pathogens, macroalgae-associ-
ated heterotrophic bacteria with significant antimicrobial 
activities intends the macroalgae as a perfect ecosystem 
harboring definite microbial diversity demonstrating a gen-
erally unexplored origin of novel antibacterial secondary 
metabolites. A larger percentage of marine host-associated 
isolates having antagonistic activities likewise emphasised 
the biotechnological prospective for targeted isolation 
of symbiotic bacteria of marine origin (Ismail-Ben et al. 
2012). Herein, we have implemented a culture-dependent 
technique to evaluate the variety of cultivable bioactive bac-
terial strains in association with intertidal macroalgae along 
the Southern Coast of Indian peninsular, to discover them as 
a source for possibly useful antibacterial agents with broad 
spectrum activity against multidrug-resistant pathogens. 
The prospective of macroalgae-associated Firmicutes and 
Gamma-proteobacteria to bring about bioactive metabolites 
was analyzed by PCR with degenerate primers of the nrps 
and pks-I genes, utilizing their conserved features.
Materials and methods
Isolation of intertidal marine macroalgae‑associated 
heterotrophic bacteria
Samples of marine macroalgae were collected from the 
intertidal region at low tide, from Mandapam situated at 9° 
17′ 0″ North, 79° 7′ 0″ East, of the Penninsular India and 
Vizhinjam located at 8.3932° North, 77.0046° East, in the 
Arabian Sea. Macroalgae belonging to the family Chloro-
phyceae, Phaeophyceae and Rhodophyceae, which include 
red algae Hypnea valentiae, Kappaphycus alvarezii, brown 
macroalgae, Sargassum myricocystum, Padina gymnospora, 
Turbinaria ornata and green algae Ulva reticulata and Caul-
erpa racemosa were collected by hand picking and scuba 
diving. The macroalgal samples were sorted out, and the 
symbiotic bacteria were isolated by following an established 
methodology (Kizhakkekalam and Chakraborty 2019). The 
colonies were differentiated according to their morphology, 
and were made axenic by restreaking them on nutrient agar 
plates.
Scanning electron microscopy analysis 
of microfouling
Scanning Electron Microscopy was performed after Vairap-
pan and Suzuki (2000) with appropriate modifications. 
Briefly, the algal thalli of approximately 0.5 cm × 0.5 cm 
size were cut into pieces and fixed in 4% glutaraldehyde, 
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in 0.1 mol L−1 sodium cacodylate buffer (pH 7.2) for 24 h. 
The specimens were then rinsed with cacodylate buffer 
(0.1 mol L−1) before post fixation in  OsO4 (1%) for 2 h at 
4 °C, followed by dehydration through a series of graded 
alcohol, before being subjected to critical-point drying. 
Dehydrated algae specimens were mounted on stubs and 
coated with a 10–30 nm layer of gold before being observed 
with a scanning electron microscope (JEOL JSM-6380LV, 
Japan).
Screening for antibacterial activity
The isolated strains were assessed for their antagonistic 
activity against wide spectrum of pathogenic strains includ-
ing aquatic and human pathogens, such as Plesiomonas 
shigelloides (ATCC 14029), Photobacterium phosphoreum 
(MTCC 11040), Yersinia enterocolitica (MTCC 859), Strep-
tococcus pyogenes (MTCC 1924), Escherichia coli (MTCC 
443), Edwardsiella tarda (MTCC 2400), Aeromonas cav-
iae (ATCC 15468), Shigella flexneri (MTCC 1457), Vibrio 
harveyi (LMG 4044), Aeromonas hydrophila (ATCC 7966), 
Aeromonas salmonicida (ATCC 27013), Vibrio parahaemo-
lyticus (MTCC 451) and multidrug-resistant pathogens, 
such as methicillin-resistant Staphylococcus aureus (ATCC 
33592) and vancomycin-resistant Enterococcus faecalis 
(ATCC 51299). The inhibitory potential of each strains were 
screened by spot over lawn assay. In short, the pathogenic 
bacterial strains were grown up to the exponential phase 
in NB (nutrient broth) with 1–2% NaCl. Thereafter, under 
sterile conditions, a lawn was made on Mueller–Hinton agar 
(MHA, HiMedia, Mumbai, India) plates by swabbing them, 
upon which pure colonies of the bacteria were spotted in 
6 mm diameter. The plates were incubated for 24–72 h at 
30 °C, and the inhibition zone observed around the isolates 
was recorded using antibiotic zone scale (HiMedia, Mumbai, 
India).
Characterization of the bioactive isolates
Seven bacterial strains exhibiting significantly greater anti-
bacterial activity against the tested pathogens were fur-
ther identified by classical biochemical methods followed 
by Biolog characterization (GEN III Microplate), Matrix 
Assisted Laser Desorption/Ionization (MALDI) biotyping 
(IMTECH, India) and 16S rRNA gene sequencing. The 
identification of isolated bacteria was first performed by 
new GEN III MicroPlate™ test panel of the Biolog system, 
which provided information on the phenotypic fingerprint 
of the microorganism, and could be used to identify them in 
species level. Fresh overnight cultures of the isolates were 
tested according to the manufacturer’s protocol. Bacterial 
suspensions were prepared by taking pure bacterial colonies 
from the plate surface by a sterile cotton swab and mixing it 
in 5 mL of 0.85% saline solution. Bacterial suspension was 
adjusted in IF-0a to achieve a 90–98% transmittance (T90) 
using a Biolog turbidimeter. Briefly, about 150 µL of the 
suspension was distributed into each well of a Biolog GEN 
III microplate, and the plates were then incubated at 26 °C 
in an Omnilog Reader/Incubater (Biolog). After incubation, 
the phenotypic fingerprints of purple wells were compared 
to the Biolog’s extensive species library for species level 
identification of the isolates.
Further the characteristic identification was performed 
with the bacterial surface protein analysis using MALDI-
TOF biotyping, where small pure colonies of 12–24 h grown 
cultures were suspended in sterile distilled water (300 μL). 
It was then washed thrice with absolute ethanol (900 μL) 
and 70% formic acid (50 μL) followed by centrifugation 
(at 12000 rpm for 2 min). The supernatant and pellet were 
separated, whereas the pellet was dissolved in acetonitrile 
(~ 50 μL) and centrifuged at 12,000 rpm for 2 min. A volume 
of 1 mL of the supernatant was loaded on target and dried 
followed by analysis using MALDI-Biotyper (Microflex, 
Bruker, Germany).
The identities of the heterotrophic bacteria were further-
more affirmed by sequencing their 16S rRNA fingerprint 
regions. Isolates showing significant and consistent inhibi-
tory activity against the pathogens tested were selected, and 
DNA was extracted from the bacteria grown in NB (nutri-
ent broth) with 1–2% NaCl by phenol–chloroform method. 
Further, the quality of these bacterial DNA was assessed by 
agarose gel electrophoresis, and their concentrations were 
recorded using a Biophotometer (Applied Biosystems, 
USA). A total volume of 25 μL of PCR mix was prepared 
with 10× buffer (Sigma), 0.25 mM of dNTPs (Sigma), 
0.5 mM of forward and reverse primers (Sigma), 1 ng of 
DNA and 0.3 U of Taq DNA polymerase enzyme (Sigma) 
with 3 mM of  MgCl2 for amplifying the specific regions. The 
following cycling conditions were used: initial denaturation 
for 5 min at 94 °C, then 30 cycles of 95 °C for 1 min, 58 °C 
for 1 min, and 72 °C for 2 min, with a 5 min final exten-
sion at 72 °C (Applied Biosystems, USA). Universal primer 
sequences used for the amplification of 16S rRNA region 
was listed in Table 3 (Weisburg et al. 1991). The bands on 
gel with the expected size on the agarose gel were purified 
by following the manufacturer’s protocol of GelElute™-gel 
extraction kit (Sigma), and sequenced. Similar sequences 
were searched in the gene database with BLAST search 
tool and further deposited in GenBank. Each sequence was 
aligned with CLUSTALW Software (Bioedit program) 
against reference sequences, and the aligned sequence set 
was given as input for phylogenetic tree construction pro-
gram. The neighbour-joining method based on the Kimura 
two-parameter model and bootstrap analysis with 1000 rep-
lications was used to infer the evolutionary history. MEGA6 
was used to perform evolutionary analyses.
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Antibiotic sensitivity of the selected bacteria
Antibiotic sensitivity of the organisms was determined using 
commercially available antibiotic impregnated octadiscs 
(HiMedia) consisting of eight antibiotics—cephalothin, clin-
damycin, trimoxazole, erythromycin, gentamicin, ofloxacin, 
penicillin-G and vancomycin placed on the centre of the 
Mueller–Hinton Agar plates with the culture of candidate 
bacteria, according to the guidelines set forth by the Clinical 
and Laboratory Standard Institute guidelines (CLSI 2009).
Extraction of bacterial metabolites
The bacteria were cultured on nutrient agar plates with 1–2% 
NaCl at pH 8. As the symbiotic bacteria Shewanella algae 
(MTCC 12715) and Bacillus amyloliquefaciens (MTCC 
12716) secrete the bioactive compounds to the surrounding 
medium, the solid agar was separated aseptically by remov-
ing the bacteria at stationary phase and were extracted com-
prehensively with solvent ethyl acetate for 5 h (three times) 
at a temperature not beyond the boiling point of the solvent 
before being concentrated in vacuo with a rotary vacuum 
evaporator (Heidolph, Schwabach, Germany) at about 40 °C. 
The residues obtained were stored for further analyses at 
4 °C.
Antibacterial activity of organic extract
Disc diffusion method
The disc diffusion method of Bauer et al. (1966) was initially 
used to study the antibacterial activity of the crude extracts 
against clinical as well as aquatic pathogens. Sterile discs 
(6 mm) containing 30 µg of each extract was prepared from 
a 1 mg stock solution. MHA plates were inoculated with 
overnight grown pathogenic organisms of  107 cfu mL−1 (cfu: 
colony forming unit). The discs with bacterial extracts were 
then placed on the surface of these MHA plates and incu-
bated for 24–72 h at 37 °C. The results were noted down 
by measuring the size of zone of inhibition using antibiotic 
zone scale (HiMedia). Ethyl acetate was used as negative 
control and commercially available antibiotic discs (HiMe-
dia) as positive control.
Immersion bioautography
The crude organic extracts (10 μL, 1.0 mg/mL) were loaded 
onto TLC plates in a thin band and eluted using 60% ethyl 
acetate/n-hexane, as the mobile solvent system. The devel-
oped plates were then dried in a fast moving air stream in 
order to remove solvent traces on the plates. The overnight 
grown bacterial cultures of pathogens were used to inoculate 
the MHA plates. The prepared chromatograms were kept in 
sterile petriplates and MHA mixed with each culture broth 
was poured at a temperature lesser than 40 °C. Further, the 
plates were incubated overnight with 100% relative humid-
ity, at 35 °C, and in the dark. After 24 h of incubation, the 
plate was sprayed with a solution of 2 mg/mL tetrazolium 
salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT,  Sigma®, USA), before being incubated 
for 2 h (Suleimana et al. 2009). The white bands indicated 
the absence of reduction of MTT to the coloured formazan 
because of the presence of compounds that inhibited the 
growth of the test organisms.
Minimum inhibitory concentration and minimum 
bactericidal concentration
Minimum inhibitory concentration (MIC) calculation was 
carried out according to the Clinical and Laboratory Stand-
ard Institute guidelines (CLSI 2012). The MIC test was 
performed using MH broth, which was supplemented with 
1–2% NaCl. In a 96 well plate, 11 pathogens and the crude 
extracts were added in different dilutions. Chloramphenicol 
antibiotic was used as the positive control and ethyl acetate 
as the negative control. Briefly, the antibacterial extracts 
were serially diluted (1:1), through sterile MH broth in a 
microwell plate, and the standardized inoculums, which 
were identical to the volume of the diluted crude extract, 
were added to each dilution well, bringing the microbial 
concentration to about 500,000 cells/mL. The blank was set 
with the nutrient broth and the microplate was incubated 
at 35 °C for 18 h. Further, it was observed for microbial 
growth, which was indicated by measuring the absorbance 
followed by addition of a tetrazolium salt MTT, where MTT 
(0.5%) was used as the indicator stain of growth. The last 
wells in the dilution series, which did not exhibit growth, 
were found to correspond with the MIC of the antibacte-
rial agent. The minimum bactericidal concentration (MBC) 
was determined by swabbing 10 μL of the dilutions from 
the incubated plates to spot the colony formation, and the 
lowest concentration at which the colony formation was not 
observed, were recorded.
Time‑kill assay
Time-kill assay was performed to define the primary mode 
of action of the antibacterial agents present in the extracel-
lular metabolites of macroalgae associated bacteria under 
the study. The assay was carried out by macro-dilution 
method as per the Clinical and Laboratory Standards Insti-
tute guidelines (CLSI 2012). Approximately  105 cfu/mL of 
exponentially growing bacterial cells in inoculum suspen-
sions (MR S. aureus and E. coli) were used in this test. The 
crude extracts were added to 10 mL of inoculum with final 
concentrations corresponding to ½ × MIC, 1 × MIC and 
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2 × MIC. A control containing the bacterial strain without 
the extract was incorporated in each trial. Further, the inocu-
lum cultures were incubated on an orbital shaker at 200 rpm 
at 37 °C. Aliquots were removed from the inoculum after 
timed intervals of incubation (i.e., 0, 0.5, 1, 2, 4, 8, 12 and 
24 h), and serial tenfold dilutions were prepared in saline, 
as needed. The numbers of viable cells were observed by 
the plate count technique, briefly, plating 25 µL of each 
dilution on a MHA plate, whereas all plates were incubated 
for 24 h at 37 °C. Resulting data were evaluated as killing 
curves by plotting the  log10 cfu/mL versus time (h), and the 
change in bacterial concentration was determined. Bacte-
ricidal activity, i.e., the viable bacterial cell count for the 
time-kill end point determination, was defined as a reduc-
tion of ≥ 3log10 cfu/mL comparative to the initial inoculum, 
whereas, bacteriostatic activity relating to < 3log10 cfu/mL 
was found to decrease relative to the initial inoculum suspen-
sions (Petersen et al. 2007).
Live/dead assay
The bacteria exhibiting higher antagonistic potential and 
complete bactericidal activity were further tested with live/
dead assay. The viability assay was executed using the live/
dead BacLight™ bacterial viability staining kit L7012 
(Invitrogen, Molecular Probes, USA), which included two 
nucleic acid-binding stains, i.e., SYTO 9 and propidium 
iodide (PI). These stains when used in a suitable mixture, 
the live bacteria with intact membranes fluoresce green, 
whereas bacteria with damaged membranes fluoresce red 
(Singh 2006). The bacterial strains of E. coli and MRSA 
were grown overnight at 30 °C in MH broth before being 
centrifuged and washed with NaCl, (0.85%). Afterwards, 
the bacteria were suspended in saline solution to attain an 
 OD600 nm of 0.150 ± 0.02, and 1 mL of each cell suspension 
was kept in contact with the crude extract (at equivalent 
MIC) for 1 h. Control was set with cell suspension in 10% 
DMSO, without the extract. Further, pathogenic bacte-
rial cultures were diluted in saline (1:10) and each diluted 
suspension (300 μL) was filtered through a Nucleopore™ 
(Whatman) black polycarbonate membrane of 0.22 mm 
pore size and stained with 250 mL of diluted SYTO 9, a 
green-fluorescent nuclear counterstain and equal amount of 
diluted PI. Further, the dyes were kept to react in the dark at 
27 ± 3 °C, for 15 min. The membrane was then mounted on 
BacLight™ mounting oil, as mentioned in the manufactur-
er’s protocol. A LEICA DMLB2 microscope with mercury 
lamp HBO/100W/3 incorporating a color digital camera to 
acquire images using IM50 software (LEICA) and a 100× 
oil immersion fluorescence objective was used to observe the 
stained bacteria. The optical filter combination for optimal 
viewing of stained mounts was consisted with a 480–500 nm 
excitation filter bearing a 485 nm emission filter (Chroma 
61000-V2 DAPI/FITC/TRITC).
Identification of secondary metabolite genes
The genes encoding pks-I and nrps were amplified with 
different sets of degenerate primers in order to screen the 
secondary metabolite genes responsible for the biosynthetic 
potential of bacterial isolates. The primers used for the anal-
ysis were given in Table 3. Polymerised chain reaction was 
performed in a total volume of 25 µL having 10× buffer 
with  MgCl2 (Sigma), 0.25 mM dNTPs (Sigma), 1.0 mM of 
each primer (Sigma), 1 ng DNA, and 0.3 U Taq polymer-
ase (Sigma). PCR conditions were set as initial denatura-
tion time of 5 min at 94 °C followed by 30 cycles of 30 s at 
94 °C, 30 s at 56 °C, 1 min at 72 °C, and a final extension 
of 5 min at 72 °C. Agarose gel (1.5%) was used to detect 
the amplified products as fragments, by agarose gel elec-
trophoresis, and bands of 700–800 bp and 1000–1400 bp 
were considered as products of pks-I and nrps genes, respec-
tively. The products of the estimated size (pks-I ~ 700 bp and 
nrps ~ 1000 bp) were then purified with Gel Elute™ Gel 
Extraction Kit (Sigma). The sequences obtained were further 
submitted in the NCBI GenBank.
Statistical analysis
The variances (ANOVA) between various results were ana-
lyzed by Statistical Program for Social Science (SPSS, ver. 
13.0, SPSS Inc., Quarry Bay, HK), and was used for assess-
ing the significant differences between the means. Data were 
expressed as mean ± standard deviation of three replicates, 
and significant differences were represented as P < 0.05.
Results
Isolation of heterotrophic bacterial strains 
associated with intertidal macroalgae 
and antibacterial screening
Bacteria associated with intertidal macroalgae (Figure 
S1) belonging to Phaeophyceae, Rhodophyceae and 
Chlorophyceae along the Southern coast of India, were 
isolated and screened for their bioactive potentials. A 
total of 148 bacterial strains were isolated from 33 dif-
ferent macroalgae, and 77 of them (53%) showed sig-
nificant antibacterial activity in the preliminary screen-
ing. Single, pure colonies of the active strains were made 
and preserved with sterile glycerol at − 80 °C. Among 
the above-mentioned 77 isolates, only 23 were thrived 
in withstanding further laboratory sub-culturing, and 
could conserve the bioactivity. High-resolution scanning 
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electron microscopy images (Fig. 1a) inferred the sym-
biotic interaction between macroalgae and bacteria espe-
cially on the thalli surface. Among them, seven strains 
with greater and consistent bioactivities were selected for 
the present work, and the antibacterial properties of these 
isolates have been enlisted in Table 1. 
The green algae, U. reticulata contributed a share 
of 37% of the bioactive strains of bacteria, followed by 
brown algae S. myriocystum (23%), where, P. gymnospora 
and H. valentiae gave an equal share of 17% towards the 
total of bacterial symbionts with potential antibacterial 
properties against the test pathogens. The aggregate share 
of the macroalgae K. alvarezii, T. ornata and C. racemosa 
towards the total number of bioactive isolates was found 
to be considerably smaller (17% of the total symbiotic 
bacteria) (Fig. 1b). Majority (83%) of the bioactive strains 
were the representatives of Gamma-proteobacteria and 
Firmicutes. The former was found to include Shewanella 
algae, Photobacterium   phosphoreum, Pseudomonas 
putida, Vibrio sp. and Aeromonas sp. The largest bacte-
rial communities belonging to Firmicutes were found to 
be Bacillus subtilis and Bacillus amyloliquefaciens fol-
lowed by Bacillus cereus and Bacillus marinus. Individ-
ual share contributed by each bacteria to the total number 
of macroalgae-associated bioactive isolates were given 
in Fig. 1c.
Identification of potential strains and 16S 
rRNA‑based phylogeny
The bacteria, which exhibited significant antagonistic prop-
erties, were categorized using diverse biochemical tests 
according to Bergey’s Manual of Determinative Bacteriol-
ogy protocol (Chakraborty et al. 2014). Phenotypic and gen-
otypic analyses grouped the potential bacteria into two major 
phyla of Gamma-proteobacteria and Firmicutes. The GEN 
III MicroPlates™ could facilitate testing of Gram-negative 
and Gram-positive bacteria in the similar test panel, which 
comprised of 71 carbon sources and 23 chemical sensitiv-
ity assays. GEN III dissected and examined the capability 
of the cell to metabolize all major classes of compounds, 
besides defining other significant physiological properties, 
such as pH, salt and lactic acid tolerance, reducing power 
and chemical sensitivity. Characteristics of biochemical 
reactions obtained from GEN III and basic cellular mor-
phological properties were described in the supplementary 
material (Table S1–S3). The isolated Shewanella spp. and 
Bacillus spp. were identified as Shewanella algae, Bacil-
lus subtilis and Bacillus amyloliquefaciens by the Biolog 
system. The identities of the bacteria were further affirmed 
with MALDI –TOF biotyping and Biolog characterization 
(Bruker Daltonik GmbH, Bremen, Germany). MALDI Bio-
typer identification of bacteria used the ribosomal protein 
Fig. 1  a Scanning electron micrographs of the macroalgae on which 
different microorganisms were attached. b Distribution of macroal-
gae-associated bacteria contributed by the representative algal hosts 
screened for the study. c Contribution (as percent share towards the 
total number of bacterial isolates with potentially greater antibacterial 
properties against the pathogens) of the individual representative bac-
terium as marine macroalgal association
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fingerprint of the cell and depends on high abundance pro-
teins (Seng et al. 2009). The producer strains were iden-
tified by MALDI biotyping as Bacillus amyloliquefaciens 
with a score of 1.90 and Shewanella algae as 2.2, which 
showed the high level confidence of identification (Figure 
S2Ab-B). Amongst the active strains, seven most potential 
strains were selected and further characterized by 16s rRNA 
genotyping and submitted in GenBank with accession num-
bers of KX272632–KX272638. The 16S rRNA sequences 
of the isolated strains were matched with the most similar 
species in the GenBank, and a phylogenetic tree was then 
made by linking the sequences of the seven bioactive strains 
with their closest relatives (Fig. 2). The bioactive strains 
were deposited in Microbial Type Culture Collection and 
Table 1  Zone of inhibition (mm) observed with spot over lawn assay of bacterial isolates against various pathogens (Gram positive and Gram 
negative)
Data were expressed as mean ± standard deviation of three replicates
B. sub1, Bacillus subtilis; B. amy2, Bacillus amyloliquefaciens; S. alg3, Shewanella algae; nd, no detectable activity
Means followed by the different superscripts (a–c) within the same row indicate significant difference (p < 0.05)
† Inhibition zone diameter (in mm)
Pathogens Inhibition zone  diameter†
B. sub1 B. amy2 B. amy2 B. sub1 S. alg3 S. alg3 S. alg3 B. sub1
Vibrio parahaemolyticus (MTCC 451) 32a ± 0.91 32a ± 0.60 30a ± 0.74 nd 27a ± 0.07 13c ± 0.63 nd 30a ± 0.37
Vibrio harveyi (LMG 4044) 20b ± 0.64 22b ± 0.74 20b ± 0.99 nd 14c ± 0.50 nd 12c ± 0.60 17b ± 0.20
Aeromonas hydrophila (ATCC 7966) 10c ± 0.30 12c ± 0.10 11c ± 0.58 nd 10c ± 0.71 nd 14c ± 0.60 20b ± 0.81
Aeromonas salmonicida (ATCC 27013) 12c ± 0.45 16b ± 0.53 13c ± 0.65 nd nd nd nd 12c ± 0.40
Plesiomonas shigelloides (ATCC 14029) 20b ± 0.82 17b ± 0.56 18b ± 0.78 nd 16b ± 0.83 nd nd 10c ± 0.73
Photobacterium phosphoreum (MTCC11040) 7c ± 0.26 10c ± 0.62 8c ± 0.43 nd 7c ± 0.60 nd nd 12c ± 0.90
Escherichia coli (MTCC 443) 8c ± 0.73 10c ± 0.25 7c ± 0.60 nd 11c ± 0.05 nd nd nd
Streptococcus pyogenes (MTCC 1924) 8c ± 0.79 10c ± 0.49 10c ± 0.65 nd 11c ± 0.09 nd 8c ± 0.63 nd
Edwardsiella tarda (MTCC 2400) 24a ± 0.16 21b ± 0.30 22b ± 0.77 nd 17b ± 0.02 nd nd 18c ± 0.67
Yersinia enterocolitica (MTCC 859) 23a ± 0.60 20b ± 0.58 21b ± 0.94 7c ± 0.70 18b ± 0.88 nd nd 14c ± 0.40
Aeromonas caviae (ATCC 15468) 22b ± 0.52 21b ± 0.81 21b ± 0.66 14c ± 0.68 12c ± 0.90 nd nd nd
Shigella flexneri (MTCC 1457) nd 10c ± 0.75 nd nd nd 10c ± 0.66 nd 11c ± 0.80
Staphylococcus aureus (MRSA) 16b ± 0.69 32a ± 0.60 11c ± 0.50 nd 16b ± 0.04 11c ± 0.90 nd nd
Enterococcus faecalis (VRE) 19b ± 0.61 20b ± 0.37 13c ± 0.11 nd 14b ± 0.03 12c ± 0.60 nd nd
Fig. 2  Phylogenetic tree 
obtained from 16S rRNA 
gene sequences of the selected 
strains, showing evolution-
ary relationships between 
bacterial isolates associated 
with intertidal macroalgae. 
The evolutionary history was 
inferred by using the Maximum 
Likelihood Method based on the 
Kimura 2-parameter model. The 
tree with highest log likelihood 
(− 6375.4197) was shown. The 
percentage of trees in which 
associated taxa were clustered 
together, was shown next to the 
branches. There were a total of 
1577 positions in the final data-
set. Evolutionary analyses were 
conducted in MEGA6. Candi-
date strains of B. amyloliquefa-
ciens (KX272634) and S. algae 
(KX 272635) were highlighted
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Gene Bank (MTCC) at the Institute of Microbial Technology 
(IMTECH), Chandigarh (India), an International Deposi-
tory Authority (IDA) under the Budapest Treaty as S. algae 
MTCC12715 and B. amyloliquefaciens MTCC12716. The 
selected strains were found to be susceptible to the antibiot-
ics used in this study (Fig. 3d, e). 
Antagonistic activity of the organic extract 
of heterotrophic bacteria
The antibacterial activity of the organic extracts of S. algae 
MTCC12715 and B. amyloliquefaciens MTCC12716 were 
assessed by various means. The zone of inhibition obtained 
from spot on lawn assay of the selected strains and disc 
diffusion assay with the organic extracts were summarized 
in Table S4 (Fig. 3a, c). Further, it was observed that the 
lowest concentration of the antibacterial agent inhibiting 
the growth of pathogenic bacteria as 3.125–25 µg/mL 
and 3.125–12.5 µg/mL for S.algae MTCC 12715 and B. 
amyloliquefaciens MTCC12716, respectively. MBC was 
noted with 10 µg/mL for S. algae and 6.25 µg/mL for B. 
amyloliquefaciens against MRSA. The results were sum-
marized in Table 2.
In immersion bioautography, the white bands speci-
fied where reduction of the tetrazolium salt, MTT to the 
coloured formazan did not occur due to the presence of 
compounds that inhibited growth of tested organisms. 
The white spot against the purple background (Fig. 3b) 
displayed on the petridish specified the fractions of sym-
biotic bacterial extract possessing antibacterial activ-
ity against MR Staphylococcus aureus. The Rf of the 
spots were intended as 0.83 and 0.54 for S. algae MTCC 
12715 and 0.97 and 0.63 for B. amyloliquefaciens MTCC 
12716 organic extracts.
Fig. 3  Antibacterial activities of the bacteria and their crude extracts 
assessed by a Spot on lawn assay, b Immersion bio autography and 
c disc diffusion method, against MRSA  (Inset: B  =  B. amylolique-
faciens and S = S. algae). Ampicillin (30 µg) was used as the posi-
tive control. Antibiotic sensitivity of the candidate bacteria tested d 
S. algae MTCC12715 and e B. amyloliquefaciens MTCC12716, with 
eight commercially available antibiotics (Octadisc, HiMedia)
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Time‑kill evaluation of bacterial extracts
To further evaluate the antibacterial effect of the extracts in 
greater depth, the killing curve analysis, which offer infor-
mation on the type of the inhibition (bacteriostatic or bacte-
ricidal) (concentration-dependent or time-dependent), was 
implemented. Time-kill analyses have been broadly used for 
in vitro studies of new antimicrobial agents as these provide 
qualitative information on the pharmacodynamics of anti-
bacterial agents (Tam et al. 2005). The kinematic interaction 
between pathogenic bacteria and extracts was observed at 
concentrations of one-half of the MIC (½ × MIC), MIC and 
two times the MIC (2 × MIC). Rapid bactericidal activity 
towards both pathogenic strains, MRSA and E. coli were 
displayed on the kill kinetic profiles, showing a ≥ 3log10 
decrease in viable cell count relative to the original. The 
time-kill assays, as expected from the determined MIC 
ratios, for B. amyloliquefaciens MTCC12716 towards 
MRSA and E. coli, were consistent with bactericidal char-
acteristic at all tested concentrations within 4 h of exposure 
(Fig. 4). The organic extracts from S. algae MTCC12715 
showed both bactericidal and bacteriostatic activity depend-
ing on time of exposure and concentration of the extract. For 
instance, Vidaillac et al. (2011) revealed that oritavancin 
displayed rapid bactericidal activity against MRSA after 9 h 
of exposure. In the present study, the kill kinetic profiles 
of both the extracts displayed higher bactericidal activity, 
i.e., within 4 h, toward MRSA and E. coli, compared to 
oritavancin.
Bactericidal efficiency
The combined usage of SYTO 9 and propidium iodide in 
a commercially available kit (BacLight™—Molecular 
 Probes®) was designated as a rapid and reliable method for 
the assessment of bacterial viability (Borges et al. 2013). 
The assay evaluated membrane integrity by selective stain 
exclusion to live and dead cells (Simões et al. 2005). B. 
amyloliquefaciens extract (MTCC 12716) with greater activ-
ity was tested with live/dead assay kit against representatives 
of Gram-positive and Gram-negative pathogens, MRSA and 
E. coli. From the results it could be observed that intact 
live cells emit a green fluorescence, whereas dead cells emit 
red fluorescence upon staining with propidium iodide. The 
increase in red fluorescence could, in turn, be considered 
as increased bactericidal activity of the bacterial extracts. 
SYTO9 is a green-fluorescent (510–540 nm) nucleic acid 
stain that is able to penetrate both healthy and damaged bac-
terial cytoplasmic membrane. After incubation with SYTO9, 
almost all bacteria emit green fluorescence upon excitation 
with blue light facilitating counting total cells. In contrast, 
propidium iodide is incapable to penetrate healthy bacteria 
and its red emission (620–650 nm) is only associated to per-
meabilized bacteria (Figure S3). When both stains are there 
in the same cell, the emission of SYTO9 has been reduced 
as a result of the displacement of one stain by the other and 
apparent quenching by Förster resonance energy transfer 
(FRET) (Stocks 2004). Live cells were observed as green, 
caused by SYTO 9 and dead cells were fluoresced in red. As 
Table 2  MIC and MBC values of the bacterial crude extracts against different indicator strains
a 30 µg/mL of crude extract
b The MBC values of chloramphenicol were described in parentheses, and expressed as µg/mL
c 30 µg/mL of  antibiotic
Indicator strain MIC (µg/mL) MBC (µg/mL) MIC (MBC)b
S. algaea B. amyloliquefa-
ciens
S. algae B. amyloliquefa-
ciens
Chloramphenicolc
Methicillin-resistant Staphylococcus aureus 12.5 12.5 10.0 6.25 6.25 (6.25)
Vancomycin-resistant Enterococcus faecalis 12.5 6.25 25.0 12.5 12.5 (6.25)
Vibrio parahaemolyticus 12.5 6.25 6.25 5.0 6.25 (10.0)
Vibrio harveyi 12.5 6.25 6.25 6.25 12.5 (6.25)
Shigella flexneri 25.0 6.25 12.0 6.25 12.5 (10.0)
Edwardsiella tarda 6.25 6.25 12.5 10.0 6.25 (6.25)
Yersinia enterocolitica 12.5 6.25 6.25 6.25 12.5 (6.25)
Aeromonas caviae 6.25 3.125 6.25 3.125 6.25 (6.25)
Aeromonas hydrophila 12.5 3.125 12.5 6.25 6.25 (6.25)
Aeromonas salmonicida 12.5 12.5 12.5 6.25 12.5 (6.25)
Plesiomonas shigelloides 25.0 12.5 25.0 12.5 12.5 (6.25)
Photobacterium phosphoreum 3.125 3.125 3.125 3.125 6.25 (6.25)
Streptococcus pyogenes 12.5 6.25 10.0 6.25 12.5 (12.5)
Escherichia coli 25.0 12.5 6.0 3.75 6.25 (6.25)
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shown in the Figure S3, the pathogens treated with crude 
extracts of B. amyloliquefaciens MTCC 12716 were almost 
red with fluorescence, indicating the high permeability of 
propidium iodide dye towards them, and most of the cells 
were dead. The control stains showed strong green fluores-
cence (Figure S3), revealing that the bacteria were viable. In 
this way, the potential of bacterial organic extract to interfere 
with membrane integrity after 1 h exposure was analysed. 
The propidium iodide uptake results appropriately attrib-
uted that the components in the B. amyloliquefaciens MTCC 
12716 organic extract might compromise the integrity of the 
cytoplasmic membrane of both pathogenic bacteria tested.
Analysis of pks and nrps gene and phylogenetic 
sequence analysis
The pks-I and nrps specific primers were positive in detect-
ing the PCR amplicons in the DNA of S. algae MTCC12715 
and B. amyloliquefaciens MTCC12716, displaying signifi-
cant homology to the sequences deposited in the NCBI 
Fig. 4  Time-kill curves of methicillin-resistant S. aureus (a, c) and E. coli (b, d) after treatment with (1): the ethyl acetate extracts of B. 
amyloliquefaciens MTCC12716 and (2): S. algae MTCC12715
Table 3  Polymerase chain 
reaction (PCR) primers used in 
this study
The primer sequences used for the PCR reaction have been represented. PCR was performed in a total vol-
ume of 25 µL containing 1x reaction buffer with  MgCl2 (Sigma), 0.25 mM of each dNTP (Sigma), 0.5 mM 
of each primers (Sigma), 1 ng DNA and 0.3 U Taq DNA polymerase (Sigma)
Primer Target Sequence (5ʹ–3ʹ) References
fd1 16S rRNA AGA GTT TGA TCC TGG CTC AG Weisburg et al. (1991)
rp2 16S rRNA ACG GCT ACC TTG TTA CGA CTT Weisburg et al. (1991)
GCF pks-1 GCSATG GAY CCSCAR CAR CGSVT Schirmer et al. (2005)
GCR pks-1 GTSCCSGTSCRTGSSCYTCSAC Schirmer et al. (2005)
KSF pks-1 GCG ATG GATCCNCAG CAG CG Zhu et al. (2009)
KSR pks-1 GTG CCG GTNCCGTGNGYYTC Zhu et al. (2009)
MTF nrps GCNGGY GGY GCNTAYGTNCC Zhao et al. (2010)
MTR nrps CCNCGDATYTTNACYTG Zhao et al. (2010)
 Archives of Microbiology
1 3
GenBank. The primers used in this work were listed in 
the Table 3. To verify the amplified product (band size 
of ~ 700 bp and ~ 1000 bp) (Fig. 5), the sequenced results 
acquired through cloning were then subjected to blastx in 
the GenBank. Afterwards, the nucleotide sequences were 
translated and the deduced amino acid sequences were also 
analysed through blastp program of NCBI. In the blast anal-
ysis report, it was observed that the positive amplicons had 
sequence similarity with S. algae type 1 pks gene (99%) 
and hybrid nrps/pks gene of B. amyloliquefaciens strains 
(99%), and they were submitted in GenBank as MH157093 
and MH157092, respectively. The maximum likelihood 
method based on the JTT matrix-based model was used to 
infer the evolutionary history (Jones et al. 1992). The tree 
with the highest likelihood (− 3511.9966) was shown, and 
the percentage of trees in which the associated taxa clustered 
together was shown next to the branches. Initial tree for the 
heuristic search were obtained automatically by applying 
neighbour-join and BioNJ algorithms to a matrix of pairwise 
distance using JTT model, and then selecting the topology 
with superior log likelihood value. There were 152 positions 
in the final dataset of evolutionary analysis, conducted in 
MEGA6. 
The phylogeny of the sequenced KS domains of S. 
algae and amino acid adenylation domain-containing pro-
tein of B. amyloliquefaciens, categorized the presumed 
amino acid sequences as bacterial pks type I and hybrid 
nrps/pks, respectively. The deduced amino acid sequence 
analysis verified that the sequences shared a conserved motif 
EAHGTG AAG DVAEF in KS domain and SGSTGKPKG in 
hybrid nonribosomal protein synthetase/type 1 polyketide 
synthetase.
Discussion
In the last decades, the incidence of human pathogens resist-
ant to several antibiotics has increased worldwide according 
to Centre for Disease Control and Prevention (CDC 2013). 
Hence, it is essential to find new alternative remedies to con-
flict or decrease the incidents of infectious diseases caused 
by drug-resistant bacteria. The interest in antibiotics derived 
from nature has increased due to the established safe status 
of certain natural products (Cowan 1999).
In the current work, heterotrophic bacteria associated with 
the intertidal macroalgae were collected along the Southern 
coast of Indian peninsular region, as the intertidal symbionts 
were reported to produce unique secondary metabolites in 
response to various stresses (Penesyan et al. 2009). Microor-
ganisms from the intertidal zones must be capable to tolerate 
fast and frequent fluctuations in environmental conditions 
including temperature, light and salinity; and are exposed 
to ultraviolet radiation, wave action, as well as phases of 
drought (Dionisi et al. 2012). Descriptive studies of surface-
associated bacteria isolated from the marine macroalgae 
were reported as early as 1875, and several new bacterial 
species and genera have been discovered from the mac-
roalgae suggesting that these species might represent an 
Fig. 5  a (Ba) Polyketide synthase/nonribosomal peptide synthetase 
hybrid gene (nrps/pks) product (~ 1000  bp) of the bioactive bac-
terium B. amyloliquefaciens MTCC 12716 associated with Hyp-
nea valentiae. (Sa) type I polyketide synthase gene (pks- I) product 
(~ 700 bp) of S. algae MTCC 12715 associated with Hypnea valen-
tiae. The amplified gene sequences for type I pks and hybrid nrps/pks 
have been submitted at the NCBI GeneBank with accession numbers 
of MH157092 and MH157093, respectively. b Molecular phylogeny 
analysis of the diverse range of ketosynthase domains as type I, II and 
III, nrps and hybrid of nrps/pks genes. The evolutionary history was 
inferred by using the maximum likelihood method based on the JTT 
matrix-based model. There were 152 positions in the final dataset. 
Evolutionary analysis was conducted in MEGA6. The sequences in 
the experiment were headed by circles
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interesting biotic environment for unearthing new bacterial 
communities (Goecke et al. 2010). Microorganisms of differ-
ent species were observed distinctly attached to the surface 
of intertidal macroalgae collected through scanning electron 
micrographs. Previously, Duan et al. (1995) reported the use 
of SEM to study the algae–bacteria interaction.
Among a total of 148 bacterial strains isolated, Gamma-
proteobacteria and Firmicutes were the predominant com-
munities present. Microbial communities living on mac-
roalgae vary in composition and number of species from 
those occurring in seawater (Longford et al. 2007). The 
most abundantly represented phylum on macroalgae being 
the Proteobacteria (Armstrong et al. 2001) followed by the 
Firmicutes, Bacteroidetes, Actinobacteria and Chloroflexi 
(Longford et al. 2007). Furthermore, the bacteria residing on 
the surfaces of marine organisms were known to comprise 
a percentage of antibiotic generating bacteria greater than 
that detected in free-living bacteria isolated from marine 
environs (Zheng et al. 2005).
Among the different macroalgal species collected, Padina 
gymnospora contributed the major share of 24% of the active 
bacterial isolates, followed by Sargassum myricocystum 
(17%). Turbinaria ornata and Caulerpa racemosa contrib-
uted equally (14% each) to the total of bacterial isolates. 
Hypnea valentiae contributed 13% of the isolates with sig-
nificantly greater antibacterial activities against the patho-
genic bacteria used. The collective share of the macroalgae 
Kappaphycus alvarezii and Ulva reticulata towards the total 
active isolates was found to be suggestively lesser (9% of the 
total symbiotic bacteria). The contribution of bioactive iso-
lates from the different macroalgal host was given in Fig. 1b. 
Interestingly, the representatives of the Gamma-proteobac-
teria were abundant (47% of the active isolates) and major-
ity of which were allied with Shewanella algae (Fig. 1c). 
Bacillus subtilis followed by Bacillus amyloliquefaciens 
(32 and 17% of the active isolates, respectively) belong-
ing to Firmicutes were found to be the second predominant 
bacterial groups. Bacillus cereus and Vibrio alginolyticus 
gave an individual share of 2% of the cumulative number of 
macroalgae-associated active isolates (Fig. 1c). Simultane-
ously, according to some findings, common strains of B. 
subtilis and B. pumilus persist as the most plentiful surface-
associated bacilli found in marine environment besides pro-
teobacteria (Ivanova et al.1999).
Since the first antibiotic from a marine bacterium was 
described in 1966 (Burkholder et al. 1966), the antibiotic 
nature of marine bacteria gained attention of the marine 
research world. In order to screen the bioactive capacities 
of the isolates under study, they were initially screened for 
antibacterial activities by spot on lawn assay, and 53% of 
the total bacteria possessed antibacterial activity against at 
least one of the pathogenic organism tested. The most active 
bacteria representing Gamma-proteobacteria and Firmicutes 
were further used for the bioprospecting studies. The bac-
teria isolated from the red marine macroalga Hypnea val-
entiae with greater activities were identified with standard 
biochemical methods, Biolog characterization and MALDI 
biotyping followed by 16s rRNA sequencing. These bioac-
tive strains were deposited in the Microbial Type Culture 
Collection and Gene Bank (MTCC) as Shewanella algae 
MTCC 12715 and Bacillus amyloliquefaciens MTCC 12716.
The bacterial metabolites were then extracted in ethyl 
acetate and antibacterial activities were primarily assessed 
with disc diffusion method. Significant activities were 
observed with an inhibition zone of 16–32  mm for B. 
amyloliquefaciens MTCC 12716 and 11–27 mm for S. algae 
MTCC 12715, against wide spectrum of pathogenic organ-
isms including MRSA and VRE. Burgess et al. (2003) iso-
lated numerous bacteria with antifouling activity from mac-
roalgae Ulva lactuca, and found that most of these bacteria 
belonged to the genus Bacillus, such as B. licheniformis and 
B. subtilis. A previous report of literature demonstrated that 
a heterotrophic Shewanella sp. isolated from macroalga Ulva 
lactuca exhibited antibacterial activity against pathogens 
with an inhibitory zone up to 9.3 mm (Kumar et al. 2011). 
Also, it was interesting to note that the MIC and MBC of the 
bacterial extracts were comparable with the commercially 
available antibiotic chloramphenicol (MIC 6.25 µg/mL). 
The macroalga-associated heterotrophic bacterial extracts 
(Bacillus and Shewanella) inhibited the growth of pathogens 
at concentration of 3.125–25 µg/mL including multi drug-
resistant strains of MRSA and VRE.
The TLC-bioautography was established to be a simple, 
effective and cost-effective technique for the separation of 
a complex mixture, and simultaneously, it localized the 
active constituents on the TLC plate, has found extensive 
application in the search for new antibiotic leads (Wag-
man and Weinstein 1973). From the bioautography results, 
well-defined inhibition bands were obtained with S. algae 
MTCC12715 as well as B. amyloliquefaciens MTCC12716 
extracts, in correspondence with the active compounds. The 
method was convenient in isolating antibacterial compounds 
because the Rf of the active compound could be used for 
further bioassay directed fractionation as an alternative of 
requiring labour intensive determination of activity of frac-
tions. This also aids to comprehend that the compound iso-
lated has been identical to that was present in the extract, and 
was not an artefact of the isolation procedure (Suleimana 
et al. 2009).
The killing curve assay discloses a time-dependent 
or a concentration-dependent antibacterial effect of the 
extracts (Pfaller et al. 2004), whereas for bacteria, this test 
has been standardized and described in M26-A document 
of CLSI (2012). The kill kinetic profiles displayed quick 
bactericidal activity against both pathogenic strains, i.e., 
MRSA and E. coli, showing a ≥ 3log10 decrease in viable 
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cell count comparative to the initial. B. amyloliquefaciens 
MTCC12716 extract killed MRSA cells after 2 h exposure, 
and it was clearly visible after 4 h, and 100% inhibition was 
achieved within 6–8 h. In the case of E. coli, the bactericidal 
activity was consistent for Bacillus extract at all tested con-
centrations, within 4 h exposure. Notably, the extracts from 
S. algae MTCC12715 exhibited bacteriostatic activity with 
MRSA strains at a concentration half its MIC, and at the 
same time the extract inhibited 100% MRSA cells within 8 h 
at MIC and 2 × MIC concentrations, and therefore, the bacte-
ricidal activity of S. algae MTCC12715 extract was found to 
depend on time of exposure and concentration of the extract 
(Fig. 4).
In the live/dead Baclight™ assay, survival rate has been 
expressed in terms of preservation of membrane integrity 
as the percentage of bacterial cells with intact membranes 
(stained with SYTO-9) to the total number of cells (Ber-
ney et al. 2007). The decease of a bacterial cell has long 
been defined as the incapability of a cell to grow to a vis-
ible colony on bacteriological media. However, with tradi-
tional culture methods the bacterial death could be observed 
only in retrospect (Postgate 1989). This assay enabled the 
differentiation between bacteria with intact and impaired 
cytoplasmic membranes; it has often been used to distin-
guish between active and dead cells (Sachidanandham et al. 
2005). From the microscopic images observed, more than 
70% of the red cells on both red filter and merged images 
indicated the complete growth inhibition of both the patho-
genic bacteria, MRSA and E. coli by B. amyloliquefaciens 
MTCC 12716 extract. The permeability of propidium iodide 
to the bacterial cells exposed to B. amyloliquefaciens MTCC 
12716 organic extract ascribed that the components in the 
extract might affect the integrity of the cytoplasmic mem-
brane of the pathogenic bacteria tested, and thereby stained 
by this selective dye.
Non-ribosomal peptide synthetase (nrps) and polyke-
tide synthase (pks), which catalyze the elongation of pol-
yketides and synthesis of oligopeptides, respectively, are 
the key enzymes of secondary metabolite biosynthesis 
(Wang et al. 2014). Many medically relevant secondary 
metabolites were found to be produced by nrps, including 
the β-lactam antibiotics and cyclosporine (Felnagle et al. 
2008) and the lipopeptide antibiotic daptomycin (Doekel 
et al. 2008). The pks produced secondary metabolites have 
also resulted in several marketed pharmaceuticals, includ-
ing lovastatin. In addition, some secondary metabolites 
are produced by a combination of nrps and pks activities 
(Brakhage 2013). The pks gene sequence amplified from S. 
algae MTCC 12715 was found to resemble 99% to the type 
1 pks of Gamma proteobacteria in BLAST search. Type 
I polyketide synthase were identified in marine S. algae, 
and they were found to code for the production of eicosa-
pentaenoic acid in the bacteria (Yazawa 1996). Based on 
a recent whole genome mining study, 31% of the Bacillus 
species were estimated to harbour nrps and pks secondary 
metabolite gene clusters, whereas 70% of these encoded 
nrps, and 30% as hybrid nrps/pks or pks (Wang et  al. 
2014). The sequence obtained from B. amyloliquefaciens 
MTCC 12716 showed similarity with the hybrid nrps/pks 
genes in the databank. These gene clusters were found to 
be responsible for the production of various polyketide and 
lipopeptide secondary metabolites in the bacteria (Aleti 
et al. 2015).
Conclusions
Presently, microbial infections have developed as a vital 
clinical threat, with associated morbidity and mortality, 
which are primarily due to the emergence of microbial 
resistance to the prevailing antimicrobial drugs. Thus, 
searches for antimicrobial susceptibility testing and dis-
covering novel antimicrobial agents have been widely 
used and continued to be developed. Marine heterotrophic 
microorganisms provide a wide range of diversity in chem-
ical structure. In addition to the molecular novelties and 
potential bioactivities, marine microbial metabolites pre-
sent a renewable supply of targeted compounds for scien-
tific investigations and commercial development. Herein, 
the activity of extracts derived from macroalgae-associated 
heterotrophic bacteria B. amyloliquefaciens MTCC 12716 
and S. algae MTCC12715 were comparable with the exist-
ing antibiotics, and therefore, could address the problem of 
resistance and re-emergence in infectious diseases. Inter-
estingly, the extracellular secondary metabolites were bac-
tericidal in nature. According to the results, these marine 
symbiotic bacteria, more specifically, B. amyloliquefaciens 
MTCC 12716, with secondary metabolite genes pks-1 and 
nrps, could be considered as a promising solution against 
the threat of antibiotic resistance.
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